Bellus Historical Cash Flow

BLU
 Stock
  

USD 11.59  0.24  2.11%   

Analysis of Bellus Health cash flow over time is an excellent tool to project Bellus Health future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Cash Flow or Change in Cash and Cash Equivalents of 108.3 M or Issuance Purchase of Equity Shares of 227.1 M as it is a great indicator of Bellus Health ability to facilitate future growth, repay debt on time or pay out dividends.Financial Statement Analysis is way more than just reviewing and evaluating Bellus Health prevailing accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bellus Health is a good buy for the upcoming year.
Continue to Trending Equities.
  

About Bellus Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Bellus balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Bellus's non-liquid assets can be easily converted into cash.

Bellus Health Cash Flow Chart

Bellus Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Bellus Health Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
Bellus Health Net Cash Flow or Change in Cash and Cash Equivalents is comparatively stable at the moment as compared to the past year. Bellus Health reported Net Cash Flow or Change in Cash and Cash Equivalents of 100.41 Million in 2021. Issuance Purchase of Equity Shares is likely to gain to about 227.1 M in 2022, whereas Net Cash Flow from Investing is likely to drop (49.5 M) in 2022.

Issuance Purchase of Equity Shares

A component of Net Cash Flow from Financing representing the net cash inflow (outflow) from common equity changes. Includes additional capital contributions from share issuances and exercise of stock options; and outflow from share repurchases.

Net Cash Flow from Financing

A component of Net Cash Flow or Change in Cash and Cash Equivalents representing the amount of cash inflow (outflow) from financing activities; from continuing and discontinued operations. Principal components of financing cash flow are: issuance (purchase) of equity shares; issuance (repayment) of debt securities; and payment of dividends & other cash distributions.

Net Cash Flow from Investing

A component of Net Cash Flow or Change in Cash and Cash Equivalents representing the amount of cash inflow (outflow) from investing activities; from continuing and discontinued operations. Principal components of investing cash flow are: capital (expenditure) disposal of equipment [CapEx]; business (acquisitions) disposition Net Cash Flow Business Acquisitions and Disposals and investment (acquisition) disposal Net Cash Flow Investment Acquisitions and Disposals.

Net Cash Flow from Operations

A component of Net Cash Flow or Change in Cash and Cash Equivalents representing the amount of cash inflow (outflow) from operating activities; from continuing and discontinued operations.
Most accounts from Bellus Health cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Bellus Health current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Bellus Health Net Cash Flow or Change in Cash and Cash Equivalents is comparatively stable at the moment as compared to the past year. Bellus Health reported Net Cash Flow or Change in Cash and Cash Equivalents of 100.41 Million in 2021. Issuance Purchase of Equity Shares is likely to gain to about 227.1 M in 2022, whereas Net Cash Flow from Investing is likely to drop (49.5 M) in 2022.

Bellus Health cash flow statement Correlations

Bellus Health Account Relationship Matchups

Bellus Health Investors Sentiment

The influence of Bellus Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bellus. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Bellus Health's public news can be used to forecast risks associated with investment in Bellus. The trend in average sentiment can be used to explain how an investor holding Bellus can time the market purely based on public headlines and social activities around Bellus Health. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Bellus Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bellus Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bellus Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Bellus Health.

Bellus Health Implied Volatility

    
  171.8  
Bellus Health's implied volatility exposes the market's sentiment of Bellus Health stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bellus Health's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bellus Health stock will not fluctuate a lot when Bellus Health's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bellus Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bellus Health's short interest history, or implied volatility extrapolated from Bellus Health options trading.

Pair Trading with Bellus Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bellus Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellus Health will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bellus Health

0.67BCTXBriaCell Therapeutics Fiscal Year End 27th of October 2022 PairCorr
0.77BEAMBeam Therapeutics Sell-off TrendPairCorr

Moving against Bellus Health

0.85KZIAKazia Therapeutics Fiscal Year End 6th of October 2022 PairCorr
0.7KLDOKaleido Biosciences Earnings Call  TodayPairCorr
0.65INMInmed Pharmaceuticals Fiscal Year End 23rd of September 2022 PairCorr
The ability to find closely correlated positions to Bellus Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bellus Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bellus Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bellus Health to buy it.
The correlation of Bellus Health is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bellus Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bellus Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bellus Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Bellus Health information on this page should be used as a complementary analysis to other Bellus Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Bellus Stock analysis

When running Bellus Health price analysis, check to measure Bellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellus Health is operating at the current time. Most of Bellus Health's value examination focuses on studying past and present price action to predict the probability of Bellus Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bellus Health's price. Additionally, you may evaluate how the addition of Bellus Health to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is Bellus Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellus Health. If investors know Bellus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellus Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1.5 B
Return On Assets
-0.22
Return On Equity
-0.37
The market value of Bellus Health is measured differently than its book value, which is the value of Bellus that is recorded on the company's balance sheet. Investors also form their own opinion of Bellus Health's value that differs from its market value or its book value, called intrinsic value, which is Bellus Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellus Health's market value can be influenced by many factors that don't directly affect Bellus Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellus Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bellus Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellus Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.